Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus

Published:2018-01-15 Issue:1 Volume:18 Page:
ISSN:1471-2377
Container-title:BMC Neurology
language:en
Short-container-title:BMC Neurol

Author:

Biessels Geert Jan^ORCID, ,Janssen Jolien,van den Berg Esther,Zinman Bernard,Espeland Mark A.,Mattheus Michaela,Johansen Odd Erik

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12883-018-1014-7.pdf

Reference36 articles.

1. International Diabetes Federation. IDF diabetes atlas - 7th edition. http://www.diabetesatlas.org . 2015. Accessed 3 octobre 2016.

2. Biessels GJ, Strachan MW, Visseren FL, Kappelle LJ, Whitmer RA. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2014;2:246–55.

3. Koekkoek PS, Kappelle LJ, van den Berg E, Rutten GE, Biessels GJ. Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol. 2015;14:329–40.

4. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64–74.

5. Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig. 2013;4:640–50.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial;Diabetes, Obesity and Metabolism;2024-01-10

2. Research Progress on the Relationship between Blood Glucose Fluctuation and Cog-nitive Dysfunction;Advances in Clinical Medicine;2023

3. Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk;Journal of Diabetes and its Complications;2022-10

4. Series: Cardiovascular outcome trials for diabetes drugs. Linagliptin, CARMELINA and CAROLINA;British Journal of Diabetes;2022-06-29

5. Occurrence of mild cognitive impairment with hyperinsulinaemia in Africans with advanced type 2 diabetes mellitus;IBRO Neuroscience Reports;2022-06